Characterization of CD4+ CTLs Ex Vivo1

The cytotoxic potential of CD8+ T cells and NK cells plays a crucial role in the immune response to pathogens. Although in vitro studies have reported that CD4+ T cells are also able to mediate perforin-mediated killing, the in vivo existence and relevance of cytotoxic CD4+ T cells have been the subject of debate. Here we show that a population of CD4+ perforin+ T cells is present in the circulation at low numbers in healthy donors and is markedly expanded in donors with chronic viral infections, in particular HIV infection, at all stages of the disease, including early primary infection. Ex vivo analysis shows that these cells have cytotoxic potential mediated through the release of perforin. In comparison with more classical CD4+ T cells, this subset displays a distinct surface phenotype and functional profile most consistent with end-stage differentiated T cells and include Ag experienced CD4+ T cells. The existence of CD4+ cytotoxic T cells in vivo at relatively high levels in chronic viral infection suggests a role in the immune response.

[1]  F. Miedema,et al.  Increased expression of CD80, CD86 and CD70 on T cells from HIV‐infected individuals upon activation in vitro: regulation by CD4+ T cells , 1996, European journal of immunology.

[2]  M. Rep,et al.  Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells , 1997, The Journal of experimental medicine.

[3]  S. Yonehara,et al.  Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. , 1996, Journal of immunology.

[4]  F. Miedema,et al.  Anti‐CD27 monoclonal antibodies identify two functionally distinct subpopulations within the CD4+ T cell subset , 1988, European journal of immunology.

[5]  F. Miedema,et al.  The CD27− subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo , 1992, European journal of immunology.

[6]  S. Fujita,et al.  Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. , 2000, Blood.

[7]  M. Roederer,et al.  11-color, 13-parameter flow cytometry: Identification of human naive T cells by phenotype, function, and T-cell receptor diversity , 2001, Nature Medicine.

[8]  J. D. Young,et al.  Perforin: structure and function. , 1995, Immunology today.

[9]  A. Singer,et al.  Recognition of MHC class I allodeterminants regulates the generation of MHC class II-specific CTL. , 1986, Journal of Immunology.

[10]  M. Smyth,et al.  NKT cells: facts, functions and fallacies. , 2000, Immunology today.

[11]  U. Wagner,et al.  Functional subsets of CD4 T cells in rheumatoid synovitis. , 1998, Arthritis and rheumatism.

[12]  R. Lechler,et al.  Individual variation in the frequency of HLA class II‐specific cytotoxic T lymphocyte precursors , 1990, European journal of immunology.

[13]  R. V. van Lier,et al.  Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. , 1987, Journal of immunology.

[14]  J. Trapani,et al.  CTL granules: evolution of vesicles essential for combating virus infections. , 1999, Immunology today.

[15]  D. Cooper,et al.  Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection. , 2001, The Journal of infectious diseases.

[16]  B. Fleischer Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture , 1984, Nature.

[17]  R. Siliciano,et al.  Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine. , 1990, Science.

[18]  V. Engelhard,et al.  Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism. , 1996, Journal of immunology.

[19]  R. Effros,et al.  Ageing of lymphocytes and lymphocytes in the aged. , 2000, Immunology today.

[20]  R. Maizels,et al.  Th1-Th2: reliable paradigm or dangerous dogma? , 1997, Immunology today.

[21]  W. Paul,et al.  Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis , 1984, The Journal of experimental medicine.

[22]  Matteo Bellone,et al.  Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11 , 1999, The Journal of experimental medicine.

[23]  F. Mami-Chouaib,et al.  Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis. , 2000, The Journal of investigative dermatology.

[24]  J. Strominger,et al.  Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Alcamí,et al.  Viral mechanisms of immune evasion , 2000, Immunology Today.

[26]  V. Maino,et al.  CD4+CD8dim T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV‐1 antigens , 2001, European journal of immunology.

[27]  A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6 , 1992, Journal of virology.

[28]  J. Trapani,et al.  Granzymes: exogenous proteinases that induce target cell apoptosis. , 1995, Immunology today.

[29]  L. Davis,et al.  Expression of CD45RB and CD27 identifies subsets of CD4+ memory T cells with different capacities to induce B cell differentiation. , 1995, Journal of immunology.

[30]  A. Rothman,et al.  Bystander Target Cell Lysis and Cytokine Production by Dengue Virus-Specific Human CD4+ Cytotoxic T-Lymphocyte Clones , 1999, Journal of Virology.

[31]  T. Waldmann,et al.  The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. , 1999, Annual review of immunology.

[32]  P. Cresswell,et al.  Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs. , 1997, Journal of immunology.

[33]  I. N. Crispe,et al.  Functional flexibility in T cells: independent regulation of CD4+ T cell proliferation and effector function in vivo. , 2000, Immunity.

[34]  T. Braciale,et al.  Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones , 1985, The Journal of experimental medicine.

[35]  E. Rosenberg,et al.  Multiple Effector Functions Mediated by Human Immunodeficiency Virus-Specific CD4+ T-Cell Clones , 2001, Journal of Virology.

[36]  R. V. van Lier,et al.  Regulation of CD27 expression on subsets of mature T-lymphocytes. , 1993, Journal of immunology.